CSIMarket
 
Seelos Therapeutics inc   (SEEL)
Other Ticker:  
 
 

Seelos Therapeutics Inc Cash flow Statement Quarterly

SEEL



Select the Financial Report:   Period:   Fiscal Year:



Cash flow Statement
(Quarterly, GAAP in millions $)

(Dec 31 2023)
12 Months
(Sep 30 2023)
9 Months
(Jun 30 2023)
6 Months
(Mar 31 2023)
3 Months
(Dec 31 2022)
12 Months
Income -37.88 -32.43 -42.93 -13.43 -73.53
Depreciation & amortization - - - - -
Amortization of Other Assets - - - - -
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense - - - - -
Restructuring & Impairment Charges - - - - -
Provision for Loan, Lease, and Other Losses - - - - -
Inventories Decrease /-Increase - - - - -
R & D, Environmental and Other Expense - - - - -
Gain (Loss) on Disposition of Assets - - - - -
Share-based Compensation 3.99 3.02 2.05 1.06 5.91
Income (Loss) from Equity Method Investments - - - - -
Fair Value Adjustment of Warrants -18.00 -14.73 12.81 0.31 -1.47
Goodwill And Intangible Asset Impairment - - - - -
Noncash Interest Expense Income Net - - - - -
Non Cash Compensation And Related Expenses - - - - -
Increase Decreasein Deferred Rental Income and Other Noncurrent Assets - - - - -
Deconsolidation Gain Or Loss Amount - - - - -
Increase Decrease In Short Term Liability Arising From Deconsolidation Of Subsidiaries - - - - -
Increase Decreasein Deferred Revenue Short Term - - - - -
Gain Losseson Extinguishment of Debt Non Cash Operating - - - - -
Gain Loss In Fair Value Of Convertible Notes - - - - -
Change In Fair Value Of Convertible Notes Payable 1.35 0.55 -0.07 2.48 0.34
Gain Loss On Forgiveness Of Note Payable - - - - -
Research And Development Expenses - - - -1.17 -1.17
Operating Lease Right Of Use Asset Amortization Expense 0.04 0.03 0.01 - -
Net Loss On Extinguishment Of Convertible Debt 9.15 5.52 0.01 - -
Increase Decrease In Operating Lease Liability -0.04 -0.03 -0.01 - -
Increase Decrease In Licenses Payable -1.00 -1.00 -1.00 - -
Income taxes - - - - -
Losses/ -gains on Investments net - - - - -
Accounts Receivable - - - - -
Increase (Decrease) in Accounts Payable 12.78 5.69 2.81 2.34 1.93
Increase (Decrease) in Accrued Liabilities -4.22 -1.09 -1.70 -1.68 3.52
Deferred Revenue and Customer Advances and Deposits - - - - -
Increase (Decrease) in Prepaid Expense and Other Assets 5.69 3.95 1.76 -1.40 -2.25
Other Working Capital - - - - -
Other Noncash Items - - - - -
Other net - - - - -
Payments for (Proceeds from) Other Operating Activities 3.54 4.08 3.87 3.51 -
Discontinued operations - - - - -
Net Cash flow from Operating Activities -23.91 -22.00 -16.25 -10.35 -61.60
Capital Expenditures - - - - -
Sale of Capital Items - - - - -
Short-term Investments Proceeds - - - - -
Short-term Investments Acq. - - - - -
Real Estate Investments - - - - -
Cash Paid For Acquired Businesses - - - - -
Restricted Cash and Investments Increase (Decrease) - - - - -
Payments for (Proceeds from) Loans - - - - -
Payments for (Proceeds from) Deposits - - - - -
Payments for (Proceeds from) Other Investments - - - - -
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank - - - - -
Payments to Acquire in Process Research and Development - - - - -
Interest in Subsidiaries and Affiliates - - - - -
Sale of businesses - - - - -
Accounts payable - - - - -
Receivables - - - - -
Payments for (Proceeds from) Other Investing Activities - - - - -
Other Net - - - - -
Discontinued operations - - - - -
Net Cash flow from Investing Activities - - - - -
Short-term debt Net - - - - -
Other borrowing transactions - - - - -0.27
Long-term debt - borrowings - - - - -
Long-term debt - repayments -7.64 -5.49 -3.60 -1.29 -1.89
Federal Home Loan Bank and Federal Funds - - - - -
Issuances/ -repurchases of Comm. Stock -1.03 -1.03 -1.07 -1.07 0.56
Partnership and Parent Transactions - - - - -
Issuances/ -repurchases of Pref. Stock - - - - -
Deposits, Annuities, Contract Holders Funds - - - - -
Other financing activities net - - - - -
Other net - - 0.00 - -
Proceeds From Payments For Sale Of Subsidiary Stock - - - - -
Gain Loss On Debt Extinguishment Notes Net - - - - -
Proceeds From Issuance Of Convertible Notes - - - - -
Proceeds From Issuance Of Common Stock In Atthemarket Offering - - - - -
Proceeds From Issuance Of Common Stock Net Of Issuance Costs - - - - -
Proceeds From Issuance Of Common Stock And Convertible Notes Payable - - - - -
Proceeds From Issuance Of Common Stock And Warrants 15.57 11.23 11.23 - -
Payments of Dividends, Preferred Stock and Preference Stock - - - - -
Dividends paid - - - - -
Net Cash flow from Financing Activities 11.38 9.05 6.56 8.87 -1.60
Effect of exchange rate on cash flow - - - - -
Discontinued operations - - - - -
Free Cash Flow -23.91 -22.00 -16.25 -10.35 -61.60
Total Cash Flow -12.54 -12.95 -9.69 -1.47 -63.20
Cash & cash equiv. at beg. of the Year - - - - -
Cash & cash equivalents at end of period - - - - -
Cash Interests paid - - - - -
Cash Income taxes paid - - - - -




Untitled Document





	
	


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com